Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Mulleman

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|February 24, 2017
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory DiseasesAnn Gils, Antonio Bertolotto, Denis Mulleman, et al.
Therapeutic Drug Monitoring|July 13, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid ArthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
Joint Bone Spine|February 24, 2012
Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?Denis Mulleman, Emilie Ducourau, Gilles Paintaud, et al.
Clinical and Experimental Rheumatology|May 19, 2017
High incidence of vertebral osteoporotic fracture within the first year after liver transplantationSarah Butin, Isabelle Griffoul, Fabien Espitalier, et al.
Joint Bone Spine|September 18, 2021
High prevalence of clinical and biological features of metabolic syndrome in patients with epidural lipomatosis: A single-center, retrospective studyHeïdi Doize, Laetitia Bodet-Contentin, Thibault Dhalluin, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Joint Bone Spine|February 21, 2006
Characteristics of patients with spinal tuberculosis in a French teaching hospitalDenis Mulleman, Saloua Mammou, Isabelle Griffoul, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2024
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across EuropeSilje Skrede, Nataša Bogavac-Stanojević, Erwin Dreesen, et al.
British Journal of Clinical Pharmacology|August 28, 2019
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritisAmina Bensalem, Denis Mulleman, Gilles Thibault, et al.
Joint Bone Spine|December 10, 2008
Infliximab for treating axial spondylarthropathy in everyday practiceIsabelle Griffoul, Bruno Giraudeau, Denis Mulleman, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|February 24, 2017
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory DiseasesAnn Gils, Antonio Bertolotto, Denis Mulleman, et al.
Therapeutic Drug Monitoring|July 13, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid ArthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
Joint Bone Spine|February 24, 2012
Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?Denis Mulleman, Emilie Ducourau, Gilles Paintaud, et al.
Clinical and Experimental Rheumatology|May 19, 2017
High incidence of vertebral osteoporotic fracture within the first year after liver transplantationSarah Butin, Isabelle Griffoul, Fabien Espitalier, et al.
Joint Bone Spine|September 18, 2021
High prevalence of clinical and biological features of metabolic syndrome in patients with epidural lipomatosis: A single-center, retrospective studyHeïdi Doize, Laetitia Bodet-Contentin, Thibault Dhalluin, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Joint Bone Spine|February 21, 2006
Characteristics of patients with spinal tuberculosis in a French teaching hospitalDenis Mulleman, Saloua Mammou, Isabelle Griffoul, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2024
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across EuropeSilje Skrede, Nataša Bogavac-Stanojević, Erwin Dreesen, et al.
British Journal of Clinical Pharmacology|August 28, 2019
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritisAmina Bensalem, Denis Mulleman, Gilles Thibault, et al.
Joint Bone Spine|December 10, 2008
Infliximab for treating axial spondylarthropathy in everyday practiceIsabelle Griffoul, Bruno Giraudeau, Denis Mulleman, et al.
Pageof 10